Tagged with Pharma,

Dimitris Demos – CEO, DEMO Pharma
Greece’s EU Recovery Funds: Unlocking Potential in Manufacturing, Primary Care & Digitalisation
France Pharma Roundup: Medicine Shortages; CARMAT’s Artificial Heart Study; Sanofi/Innate Expanded Deal; Cellectis Funding
Becoming a ‘Pan African’ Pharma Champion
A New Chapter for Angelini with Ex-Gilead Exec at the Helm
Five Biotech Leadership Lessons from Redx Pharma CEO Lisa Anson
Vietnamese Pharma in 2022 & Beyond: Four Things to Know
All Change in Italian Pharma with New Country Leads at Ipsen, Gilead & Teva
Chinese Pharma in 2022 & Beyond: Five Things to Know
Indian Manufacturers Still on FDA Radar as Quality Reprimands Hit Biocon and Cipla
2022 HKEX Biotech Listings Drop from Last Year’s Record High
Australia Pharma News: Unification of CSL’s Business Units, New USD 173 Million Research Centre, Acquisition of CDMO Luina Bio …
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here